D'Incalci Maurizio, Steward William P, Gescher Andreas J
Pharmacological Research Institute Mario Negri, Milan, Italy.
Lancet Oncol. 2005 Nov;6(11):899-904. doi: 10.1016/S1470-2045(05)70425-3.
A lot of information has been gathered on cellular mechanisms by which chemopreventive phytochemicals, such as curcumin (a spice in curry) or epigallocatechin gallate (extracted from tea), interfere with carcinogenesis. A comparison of this knowledge with what we know about molecularly targeted chemotherapeutic agents suggests that it might be worthwhile to investigate the usefulness of such phytochemicals in the treatment of established malignant diseases. Phytochemicals use a plethora of antisurvival mechanisms, boost the host's anti-inflammatory defence, and sensitise malignant cells to cytotoxic agents. The restricted systemic availability of agents such as curcumin and epigallocatechin gallate, needs to be taken into account if they are to be developed as cochemotherapeutic drugs.
关于化学预防植物化学物质(如姜黄素,咖喱中的一种香料;或表没食子儿茶素没食子酸酯,从茶叶中提取)干扰致癌作用的细胞机制,已经收集了大量信息。将这些知识与我们对分子靶向化疗药物的了解进行比较后表明,研究此类植物化学物质在治疗已确诊恶性疾病中的效用可能是值得的。植物化学物质利用大量抗生存机制,增强宿主的抗炎防御,并使恶性细胞对细胞毒性药物敏感。如果要将姜黄素和表没食子儿茶素没食子酸酯等药物开发为联合化疗药物,就需要考虑它们有限的全身可用性。